Global Community
Our community narratives are driven by numbers and valuation.
Community Investing Ideas
Global Weekly Picks
Everyone's Terrified Microsoft Will Keep Spending. I'm Terrified They'll Stop.
The academically fascinating Tesla
Poised for success
Lucid Diagnostics' EsoGuard is a novel screening tool for esophageal cancer. It is relatively non-invasive and may become widely accepted soon.Read more
Grid Metals will see a transformative 21.5x future PE change
# Cesium Geopolitics and Valuation Implications for Grid Metals’ Falcon West ## Executive summary Cesium’s strategic value is rising because its real-world supply chain is exceptionally concentrated and sits inside an increasingly weaponized trade environment. Public government data still characterizes cesium and rubidium markets as small, opaque, and supply-constrained, with no transparent exchange pricing and limited public production reporting.Read more
The Market Is Sleeping on This Parkinson's Biotech - And I Think That's a Mistake
Gain Therapeutics: The Under-the-Radar Biotech With Big Parkinson’s Potential Key Takeaways Gain Therapeutics (GANX) is developing GT-02287 – an oral, first-in-class, potentially disease-modifying treatment for Parkinson’s disease targeting the GCase enzyme pathway. Parkinson’s disease represents a $4 billion U.S. market with zero approved disease-modifying therapies.Read more
The Company Powering AI’s Data Traffic, Not Its Headlines
Rating: Speculative Buy / High Risk Style: AI infrastructure “picks-and-shovels” growth name Core debate: Is AAOI a genuine bottleneck asset in AI networking, or a cyclical optics supplier temporarily enjoying peak demand and peak multiples? Executive view Applied Optoelectronics is no longer just a small-cap optical component company.Read more
Meta Bright: Rising fuel costs could gradually accelerate the shift to EVs and rooftop solar
When fuel costs stay high or become more volatile, the effect usually goes beyond just higher transport bills. Over time, it also pushes households, businesses and property owners to look more seriously at alternatives that can reduce long-term operating costs.Read more
Is Prysmian still “just a cable manufacturer”?
Rating: Buy / Quality Compounder with Cyclical Entry Risk Style: Infrastructure-led industrial compounder Core debate: Is Prysmian still “just a cable manufacturer,” or has it become a scarce, strategic infrastructure platform leveraged to electrification, grid bottlenecks, and AI-era connectivity? Executive view Prysmian is one of the highest-quality ways to invest in the physical backbone of electrification and digitalization.Read more
A Case for Guanajuato Silver (TSXV:GSVR) to reach (low end) CAD$ 3.96 (high end) CAD$ 12.50 by 2030
Key Assumptions Metal Prices: Gold at $4,500/oz (80% above ~$2,500/oz) and silver at $100/oz (233% above ~$30/oz), held constant for simplicity. Real Inflation Rate: 8% annually, increasing operating costs (e.g., all-in sustaining costs, AISC) and potentially compressing valuation multiples.Read more
Is Tesla a Stock or a Call Option? - A valuation nightmare!
TLDR Tesla is not being valued like a car company , but like a bundle of future bets sitting on top of a real operating business. The real upside the market is paying for is Robotaxi, Optimus / Physical AI, and Elon Musk premium.Read more
Springer REE deposit valuation
I have been reviewing Volta Metals ’ recently updated Springer REE deposit mineral resource estimate (https://www.voltametals.ca/s/VLTA-NR-2026-02-23.pdf) and wanted to contextualize its scale on an in-situ value basis relative to more conventional precious and base metal deposits. In the independent Springer resource estimate conducted by SLR Consulting, a net metal revenue (“NMR”) of C$159/t is applied to the 56.6 Mt of indicated resources and C$128/t to the 119.5 Mt of inferred resources, implying a combined in-situ value of approximately C$24.3 billion.Read more
